Clinical Trial Update: Cool.Click™ Adolescent Transition Study: Study of Saizen® in Subjects With Childhood-onset Growth Hormone Deficiency [Phase 3]

View source ↗

Summary

Phase 3 adolescent transition study evaluating Saizen for childhood-onset growth hormone deficiency has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Childhood-onset Growth Hormone Deficiency
• Pituitary Dwarfism

Drugs mentioned

• Saizen (somatropin)

Snippet

Sponsor: EMD Serono | Conditions: Childhood-onset Growth Hormone Deficiency, Pituitary Dwarfism | Phase 3 | Status: COMPLETED | Results posted: 2010-06-22